These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29306541)

  • 1. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.
    Bhutiani N; Scoggins CR; McMasters KM; Ethun CG; Poultsides GA; Pawlik TM; Weber SM; Schmidt CR; Fields RC; Idrees K; Hatzaras I; Shen P; Maithel SK; Martin RCG
    Surgery; 2018 Apr; 163(4):726-731. PubMed ID: 29306541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resectable intrahepatic and hilar cholangiocarcinoma: Is margin status associated with survival?
    Littau MJ; Kim P; Kulshrestha S; Bunn C; Tonelli C; Abdelsattar ZM; Luchette FA; Baker MS
    Surgery; 2022 Mar; 171(3):703-710. PubMed ID: 34872744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.
    Zhang XF; Bagante F; Chen Q; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    Surgery; 2018 May; 163(5):1114-1120. PubMed ID: 29398035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.
    Schimizzi GV; Jin LX; Davidson JT; Krasnick BA; Ethun CG; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Weber SM; Salem A; Hawkins WG; Strasberg SM; Doyle MB; Chapman WC; Martin RCG; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
    HPB (Oxford); 2018 Apr; 20(4):332-339. PubMed ID: 29169904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
    Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Margin Status on Survival After Resection of Hilar Cholangiocarcinoma in the Modern Era of Adjuvant Therapies.
    Watson MD; Baimas-George MR; Passeri MJ; Sulzer JK; Baker EH; Ocuin LM; Martinie JB; Iannitti DA; Vrochides D
    Am Surg; 2021 Sep; 87(9):1496-1503. PubMed ID: 33345594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM; Brock G; Buell JF
    HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma.
    Tran TB; Ethun CG; Pawlik TM; Schmidt C; Beal EW; Fields RC; Krasnick B; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Idrees K; Isom CA; Hatzaras I; Shenoy R; Maithel SK; Poultsides GA
    Ann Surg Oncol; 2019 Feb; 26(2):611-618. PubMed ID: 30539494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
    Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
    Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study.
    Jo HS; Kim DS; Yu YD; Kang WH; Yoon KC
    World J Surg Oncol; 2020 Jan; 18(1):3. PubMed ID: 31901228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.
    Krasnick BA; Jin LX; Davidson JT; Sanford DE; Ethun CG; Pawlik TM; Poultsides GA; Tran T; Idrees K; Hawkins WG; Chapman WC; Doyle MBM; Weber SM; Strasberg SM; Salem A; Martin RCG; Isom CA; Scoggins C; Schmidt CR; Shen P; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
    J Surg Oncol; 2018 Mar; 117(3):363-371. PubMed ID: 29284072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of positive proximal margin after resection for hilar cholangiocarcinoma: An analysis of 42 cases.
    Öter V; Özer İ; Dalgıç T; Binarbaşı C; Ulaş M; Bostancı EB
    Turk J Gastroenterol; 2019 Jan; 30(1):88-94. PubMed ID: 30301710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Klatskin tumor. A study of 15 resected cases].
    Santoro E; Sacchi M; Carboni F; Santoro R
    Chirurgie; 1999 Apr; 124(2):132-9; discussion 139-40. PubMed ID: 10349749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
    Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.